

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 8.70456468 |
| 2 | doxorubicin metabolic process (GO:0044598) | 8.70456468 |
| 3 | daunorubicin metabolic process (GO:0044597) | 8.70456468 |
| 4 | response to dietary excess (GO:0002021) | 5.57369625 |
| 5 | somite rostral/caudal axis specification (GO:0032525) | 5.54460557 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.54428348 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.50109539 |
| 8 | phenol-containing compound catabolic process (GO:0019336) | 5.27434460 |
| 9 | maintenance of protein location in nucleus (GO:0051457) | 5.07904750 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.68607149 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.60110766 |
| 12 | negative regulation of epidermis development (GO:0045683) | 4.57281145 |
| 13 | postsynaptic membrane organization (GO:0001941) | 4.55173648 |
| 14 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.45571990 |
| 15 | nucleobase catabolic process (GO:0046113) | 4.42239336 |
| 16 | regulation of response to osmotic stress (GO:0047484) | 4.36203943 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.35107243 |
| 18 | regulation of cilium movement (GO:0003352) | 4.27003731 |
| 19 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.24551848 |
| 20 | proline transport (GO:0015824) | 4.21334232 |
| 21 | histone H4-K8 acetylation (GO:0043982) | 4.18977975 |
| 22 | histone H4-K5 acetylation (GO:0043981) | 4.18977975 |
| 23 | histone H4-K12 acetylation (GO:0043983) | 4.18557518 |
| 24 | muscle organ morphogenesis (GO:0048644) | 4.15944456 |
| 25 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.08143539 |
| 26 | maintenance of protein localization in organelle (GO:0072595) | 3.99489996 |
| 27 | primitive streak formation (GO:0090009) | 3.97061740 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.96179822 |
| 29 | vocalization behavior (GO:0071625) | 3.93371577 |
| 30 | hormone catabolic process (GO:0042447) | 3.85508154 |
| 31 | positive regulation of mitochondrial fission (GO:0090141) | 3.81335396 |
| 32 | protein localization to synapse (GO:0035418) | 3.80291958 |
| 33 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.76940512 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.75671223 |
| 35 | protein localization to cilium (GO:0061512) | 3.73940731 |
| 36 | Golgi transport vesicle coating (GO:0048200) | 3.70095445 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.70095445 |
| 38 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.69063928 |
| 39 | regulation of microtubule-based movement (GO:0060632) | 3.68314564 |
| 40 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.65175172 |
| 41 | auditory behavior (GO:0031223) | 3.58677489 |
| 42 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.58000263 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.53955299 |
| 44 | negative regulation of telomerase activity (GO:0051974) | 3.53660808 |
| 45 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.51942812 |
| 46 | axonal fasciculation (GO:0007413) | 3.51873130 |
| 47 | synaptic vesicle exocytosis (GO:0016079) | 3.50855152 |
| 48 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.50390033 |
| 49 | cytidine deamination (GO:0009972) | 3.47840318 |
| 50 | cytidine metabolic process (GO:0046087) | 3.47840318 |
| 51 | cytidine catabolic process (GO:0006216) | 3.47840318 |
| 52 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.47504659 |
| 53 | notochord development (GO:0030903) | 3.47078792 |
| 54 | GDP-mannose metabolic process (GO:0019673) | 3.45258295 |
| 55 | rRNA transcription (GO:0009303) | 3.44527274 |
| 56 | synapse assembly (GO:0007416) | 3.42331945 |
| 57 | intestinal epithelial cell development (GO:0060576) | 3.37229941 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.36957126 |
| 59 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.35195694 |
| 60 | protein polyglutamylation (GO:0018095) | 3.34609465 |
| 61 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.33656461 |
| 62 | dendritic spine morphogenesis (GO:0060997) | 3.32213491 |
| 63 | nucleoside transmembrane transport (GO:1901642) | 3.30920526 |
| 64 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.30192976 |
| 65 | sequestering of actin monomers (GO:0042989) | 3.28136574 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.27231628 |
| 67 | quinone metabolic process (GO:1901661) | 3.26428121 |
| 68 | regulation of synapse structural plasticity (GO:0051823) | 3.25807751 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 3.24507546 |
| 70 | synaptic transmission, glutamatergic (GO:0035249) | 3.23852096 |
| 71 | cardiovascular system development (GO:0072358) | 3.22145725 |
| 72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.21830346 |
| 73 | nonmotile primary cilium assembly (GO:0035058) | 3.21733478 |
| 74 | behavioral response to nicotine (GO:0035095) | 3.21571953 |
| 75 | neuron recognition (GO:0008038) | 3.20378102 |
| 76 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.20171126 |
| 77 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18039646 |
| 78 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.17344165 |
| 79 | glutamate secretion (GO:0014047) | 3.17020923 |
| 80 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.15973579 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.15761135 |
| 82 | establishment of mitochondrion localization (GO:0051654) | 3.12736209 |
| 83 | retinal ganglion cell axon guidance (GO:0031290) | 3.11944870 |
| 84 | melanosome transport (GO:0032402) | 3.11060333 |
| 85 | glandular epithelial cell differentiation (GO:0002067) | 3.10495660 |
| 86 | negative regulation of smoothened signaling pathway (GO:0045879) | 3.10232914 |
| 87 | establishment of melanosome localization (GO:0032401) | 3.08940054 |
| 88 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.08236899 |
| 89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.07021211 |
| 90 | microtubule severing (GO:0051013) | 3.06791341 |
| 91 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.06442045 |
| 92 | mechanosensory behavior (GO:0007638) | 3.05724212 |
| 93 | cullin deneddylation (GO:0010388) | 3.05577683 |
| 94 | histone H4-K16 acetylation (GO:0043984) | 3.04720006 |
| 95 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.03820531 |
| 96 | glutamate receptor signaling pathway (GO:0007215) | 3.03270418 |
| 97 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.03225357 |
| 98 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.01690488 |
| 99 | neurotransmitter secretion (GO:0007269) | 3.00701310 |
| 100 | regulation of autophagic vacuole assembly (GO:2000785) | 2.99604518 |
| 101 | positive regulation of synapse assembly (GO:0051965) | 2.99514493 |
| 102 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.98358668 |
| 103 | pigment granule transport (GO:0051904) | 2.94985004 |
| 104 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.94338867 |
| 105 | establishment of pigment granule localization (GO:0051905) | 2.93691798 |
| 106 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93346391 |
| 107 | detection of temperature stimulus (GO:0016048) | 2.92883964 |
| 108 | response to auditory stimulus (GO:0010996) | 2.92674217 |
| 109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91247950 |
| 110 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.90638356 |
| 111 | neuron fate determination (GO:0048664) | 2.87924177 |
| 112 | regulation of synaptic vesicle transport (GO:1902803) | 2.87832550 |
| 113 | neurofilament cytoskeleton organization (GO:0060052) | 2.87712045 |
| 114 | neuron-neuron synaptic transmission (GO:0007270) | 2.87673121 |
| 115 | inner ear receptor cell development (GO:0060119) | 2.87472059 |
| 116 | cellular modified amino acid catabolic process (GO:0042219) | 2.87113792 |
| 117 | protein maturation by protein folding (GO:0022417) | 2.86763927 |
| 118 | glycosphingolipid biosynthetic process (GO:0006688) | 2.86537397 |
| 119 | mitochondrion distribution (GO:0048311) | 2.85996686 |
| 120 | intraciliary transport (GO:0042073) | 2.85277014 |
| 121 | C4-dicarboxylate transport (GO:0015740) | 2.85107614 |
| 122 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.81085298 |
| 123 | axon ensheathment in central nervous system (GO:0032291) | 2.78619020 |
| 124 | central nervous system myelination (GO:0022010) | 2.78619020 |
| 125 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.77572455 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.76171227 |
| 127 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76142709 |
| 128 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.74520964 |
| 129 | peptide hormone processing (GO:0016486) | 2.73904217 |
| 130 | anterior/posterior axis specification (GO:0009948) | 2.73213863 |
| 131 | thyroid hormone generation (GO:0006590) | 2.72855143 |
| 132 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.72598561 |
| 133 | positive regulation of histone deacetylation (GO:0031065) | 2.69776326 |
| 134 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69446700 |
| 135 | bone trabecula formation (GO:0060346) | 2.68760434 |
| 136 | adaptation of signaling pathway (GO:0023058) | 2.68224623 |
| 137 | epithelial cilium movement (GO:0003351) | 2.68008153 |
| 138 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.67398077 |
| 139 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.67258388 |
| 140 | response to pheromone (GO:0019236) | 2.66158029 |
| 141 | tachykinin receptor signaling pathway (GO:0007217) | 2.65996193 |
| 142 | embryonic axis specification (GO:0000578) | 2.65667255 |
| 143 | synapse organization (GO:0050808) | 2.65218833 |
| 144 | endocrine pancreas development (GO:0031018) | 2.64989229 |
| 145 | positive regulation of amino acid transport (GO:0051957) | 2.62899592 |
| 146 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.62202283 |
| 147 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.61713760 |
| 148 | cilium morphogenesis (GO:0060271) | 2.61506858 |
| 149 | synaptic transmission, cholinergic (GO:0007271) | 2.61357400 |
| 150 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.61107275 |
| 151 | ventricular system development (GO:0021591) | 2.60451301 |
| 152 | protein complex biogenesis (GO:0070271) | 2.59288404 |
| 153 | locomotory exploration behavior (GO:0035641) | 2.59094112 |
| 154 | positive regulation of TOR signaling (GO:0032008) | 2.58875548 |
| 155 | melanosome localization (GO:0032400) | 2.58525318 |
| 156 | platelet dense granule organization (GO:0060155) | 2.57998500 |
| 157 | short-term memory (GO:0007614) | 2.57302314 |
| 158 | negative regulation of axon extension (GO:0030517) | 2.57270940 |
| 159 | protein deneddylation (GO:0000338) | 2.55901714 |
| 160 | negative regulation of bone resorption (GO:0045779) | 2.55159271 |
| 161 | regulation of development, heterochronic (GO:0040034) | 2.54470713 |
| 162 | positive regulation of protein deacetylation (GO:0090312) | 2.54299854 |
| 163 | adult walking behavior (GO:0007628) | 2.53486351 |
| 164 | regulation of neurotransmitter levels (GO:0001505) | 2.53320521 |
| 165 | protein-cofactor linkage (GO:0018065) | 2.52738193 |
| 166 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.52671805 |
| 167 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.51393882 |
| 168 | NADH dehydrogenase complex assembly (GO:0010257) | 2.51393882 |
| 169 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.51393882 |
| 170 | body morphogenesis (GO:0010171) | 2.50551791 |
| 171 | regulation of feeding behavior (GO:0060259) | 2.49963519 |
| 172 | nucleoside transport (GO:0015858) | 2.49948380 |
| 173 | vitamin A metabolic process (GO:0006776) | 2.49907215 |
| 174 | positive regulation of gluconeogenesis (GO:0045722) | 2.49871340 |
| 175 | rRNA methylation (GO:0031167) | 2.49804510 |
| 176 | exploration behavior (GO:0035640) | 2.49694723 |
| 177 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.49528380 |
| 178 | chondroitin sulfate catabolic process (GO:0030207) | 2.48843101 |
| 179 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.48541198 |
| 180 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.47758506 |
| 181 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.47758506 |
| 182 | regulation of vacuole organization (GO:0044088) | 2.47681921 |
| 183 | negative regulation of telomere maintenance (GO:0032205) | 2.47333985 |
| 184 | stress granule assembly (GO:0034063) | 2.47052876 |
| 185 | behavioral fear response (GO:0001662) | 2.45751977 |
| 186 | behavioral defense response (GO:0002209) | 2.45751977 |
| 187 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.45461959 |
| 188 | ATP synthesis coupled proton transport (GO:0015986) | 2.45461959 |
| 189 | regulation of timing of cell differentiation (GO:0048505) | 2.44731903 |
| 190 | startle response (GO:0001964) | 2.40590987 |
| 191 | neuronal action potential (GO:0019228) | 2.40464059 |
| 192 | regulation of vesicle fusion (GO:0031338) | 2.39569257 |
| 193 | establishment of synaptic vesicle localization (GO:0097480) | 2.39565665 |
| 194 | synaptic vesicle transport (GO:0048489) | 2.39565665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.94647341 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.94647341 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.94647341 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.34559958 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.75872736 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11266895 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.79036292 |
| 8 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.75654837 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.70531428 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.62028597 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.61895894 |
| 12 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.57014715 |
| 13 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.54451188 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.23729355 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19058986 |
| 16 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.15354581 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.05774514 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.05489515 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04252598 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03566235 |
| 21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.98104993 |
| 22 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.95648426 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.94935282 |
| 24 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.94196280 |
| 25 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.93778006 |
| 26 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.90995053 |
| 27 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.88338108 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86631719 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80997503 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80328754 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78809332 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77363328 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77097800 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.74114161 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73068771 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71047073 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70617563 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65277048 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63569270 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63380629 |
| 41 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.63369917 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63191855 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.62021952 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.62021952 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.61719365 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.61515274 |
| 47 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.60360083 |
| 48 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60219354 |
| 49 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.59489493 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55958131 |
| 51 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.55892918 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55395403 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54503805 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54141650 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53952732 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.53771281 |
| 57 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.51471995 |
| 58 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.51401316 |
| 59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50613926 |
| 60 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48585939 |
| 61 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.47662883 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.45972939 |
| 63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.45618731 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45399663 |
| 65 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42029179 |
| 66 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40788027 |
| 67 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40144157 |
| 68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39061017 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.38349951 |
| 70 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.37571135 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37406724 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35699421 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34395824 |
| 74 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.34354249 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33942663 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33833869 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33464346 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.32888331 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32869146 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32648250 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32293130 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.30547425 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29131553 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28558258 |
| 85 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.27483973 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25026083 |
| 87 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24133501 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23725809 |
| 89 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.23366929 |
| 90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22529566 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.21761755 |
| 92 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.21074461 |
| 93 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20983264 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20126234 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19807607 |
| 96 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.19045086 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18686278 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18256089 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18211887 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18161113 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17808362 |
| 102 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14733100 |
| 103 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14394975 |
| 104 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11342417 |
| 105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09734859 |
| 106 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09517371 |
| 107 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.09156218 |
| 108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09142799 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09142799 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08808694 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08140826 |
| 112 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08123242 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07835884 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07835884 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07627814 |
| 116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07052351 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06732379 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05983024 |
| 119 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.05607580 |
| 120 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05216673 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05179551 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04525901 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02881082 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01896325 |
| 125 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.01267848 |
| 126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01115798 |
| 127 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.00781170 |
| 128 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99764787 |
| 129 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99533545 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99527153 |
| 131 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.99416266 |
| 132 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98607928 |
| 133 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98581761 |
| 134 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98486416 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98367575 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98150024 |
| 137 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97760270 |
| 138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96693948 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96520170 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96345208 |
| 141 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95935425 |
| 142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95889457 |
| 143 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95316816 |
| 144 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94737641 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94161360 |
| 146 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93817660 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92426667 |
| 148 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92203227 |
| 149 | JUN_21703547_ChIP-Seq_K562_Human | 0.91405274 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.90718615 |
| 151 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.89646045 |
| 152 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89253806 |
| 153 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87255892 |
| 154 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86925204 |
| 155 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.86796165 |
| 156 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86301446 |
| 157 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.85988567 |
| 158 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85341441 |
| 159 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85053880 |
| 160 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84990469 |
| 161 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.84724910 |
| 162 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.83466879 |
| 163 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82740398 |
| 164 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82617305 |
| 165 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.81337284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 4.25081688 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.93497696 |
| 3 | MP0002822_catalepsy | 3.30556503 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.28228954 |
| 5 | MP0004858_abnormal_nervous_system | 3.25856368 |
| 6 | MP0003283_abnormal_digestive_organ | 3.13393292 |
| 7 | MP0001529_abnormal_vocalization | 2.91734227 |
| 8 | MP0003011_delayed_dark_adaptation | 2.91678201 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.86666660 |
| 10 | MP0000678_abnormal_parathyroid_gland | 2.84631091 |
| 11 | MP0004043_abnormal_pH_regulation | 2.83099404 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.82679101 |
| 13 | MP0005499_abnormal_olfactory_system | 2.69283516 |
| 14 | MP0005394_taste/olfaction_phenotype | 2.69283516 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.67678413 |
| 16 | MP0002254_reproductive_system_inflammat | 2.63714110 |
| 17 | MP0003121_genomic_imprinting | 2.48385093 |
| 18 | MP0003136_yellow_coat_color | 2.44456057 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.41584258 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.32492647 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.32147234 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.28865529 |
| 23 | MP0001984_abnormal_olfaction | 2.27152399 |
| 24 | MP0004270_analgesia | 2.25981575 |
| 25 | MP0002102_abnormal_ear_morphology | 2.15741414 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.05677261 |
| 27 | MP0002736_abnormal_nociception_after | 2.04046011 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.00567961 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.83617465 |
| 30 | MP0003787_abnormal_imprinting | 1.73656943 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.73182745 |
| 32 | MP0001905_abnormal_dopamine_level | 1.68298323 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.67722686 |
| 34 | MP0003119_abnormal_digestive_system | 1.60351947 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.59137888 |
| 36 | MP0003938_abnormal_ear_development | 1.57324731 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.56793075 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.56302944 |
| 39 | MP0000631_abnormal_neuroendocrine_gland | 1.55499485 |
| 40 | MP0000049_abnormal_middle_ear | 1.55213713 |
| 41 | MP0005551_abnormal_eye_electrophysiolog | 1.53304987 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.51757396 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.50510389 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.46434463 |
| 45 | MP0003123_paternal_imprinting | 1.45840849 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.39524131 |
| 47 | MP0004924_abnormal_behavior | 1.39524131 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.36241825 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.35932853 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.34698800 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.33321112 |
| 52 | MP0002751_abnormal_autonomic_nervous | 1.32399272 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.32074859 |
| 54 | MP0001188_hyperpigmentation | 1.29425146 |
| 55 | MP0000955_abnormal_spinal_cord | 1.26719181 |
| 56 | MP0008789_abnormal_olfactory_epithelium | 1.26415219 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.25845832 |
| 58 | MP0003635_abnormal_synaptic_transmissio | 1.25209284 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.23245167 |
| 60 | MP0000428_abnormal_craniofacial_morphol | 1.19951130 |
| 61 | MP0005171_absent_coat_pigmentation | 1.19357133 |
| 62 | MP0005253_abnormal_eye_physiology | 1.18816385 |
| 63 | MP0001944_abnormal_pancreas_morphology | 1.17093676 |
| 64 | MP0005248_abnormal_Harderian_gland | 1.16759599 |
| 65 | MP0000566_synostosis | 1.16383774 |
| 66 | MP0000026_abnormal_inner_ear | 1.16052756 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 1.15254038 |
| 68 | MP0001486_abnormal_startle_reflex | 1.15183021 |
| 69 | MP0002233_abnormal_nose_morphology | 1.15056572 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.14068163 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.13999604 |
| 72 | MP0008569_lethality_at_weaning | 1.13936081 |
| 73 | MP0000778_abnormal_nervous_system | 1.12007139 |
| 74 | MP0002184_abnormal_innervation | 1.11259226 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.11139023 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.09738983 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 1.08155948 |
| 78 | MP0001270_distended_abdomen | 1.08044443 |
| 79 | MP0000762_abnormal_tongue_morphology | 1.07769428 |
| 80 | MP0004133_heterotaxia | 1.07625105 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.05425771 |
| 82 | MP0002693_abnormal_pancreas_physiology | 1.03776151 |
| 83 | MP0002932_abnormal_joint_morphology | 1.03193812 |
| 84 | MP0002152_abnormal_brain_morphology | 1.02613991 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.02032911 |
| 86 | MP0008877_abnormal_DNA_methylation | 1.01772453 |
| 87 | MP0010030_abnormal_orbit_morphology | 1.01631647 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 1.00536109 |
| 89 | MP0004885_abnormal_endolymph | 1.00019538 |
| 90 | MP0003755_abnormal_palate_morphology | 0.99640971 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.99532395 |
| 92 | MP0002116_abnormal_craniofacial_bone | 0.97776105 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.97119853 |
| 94 | MP0001293_anophthalmia | 0.97093118 |
| 95 | MP0003935_abnormal_craniofacial_develop | 0.96787071 |
| 96 | MP0001849_ear_inflammation | 0.96666656 |
| 97 | MP0003633_abnormal_nervous_system | 0.96446076 |
| 98 | MP0001440_abnormal_grooming_behavior | 0.96366462 |
| 99 | MP0002928_abnormal_bile_duct | 0.95918094 |
| 100 | MP0002064_seizures | 0.94611777 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.94139921 |
| 102 | MP0001970_abnormal_pain_threshold | 0.93720593 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.93231932 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.91814679 |
| 105 | MP0002272_abnormal_nervous_system | 0.90989008 |
| 106 | MP0002938_white_spotting | 0.89920478 |
| 107 | MP0005391_vision/eye_phenotype | 0.89762156 |
| 108 | MP0004147_increased_porphyrin_level | 0.89142321 |
| 109 | MP0002114_abnormal_axial_skeleton | 0.89123371 |
| 110 | MP0005187_abnormal_penis_morphology | 0.88951963 |
| 111 | MP0002557_abnormal_social/conspecific_i | 0.87844020 |
| 112 | MP0004085_abnormal_heartbeat | 0.87611198 |
| 113 | MP0003634_abnormal_glial_cell | 0.86513870 |
| 114 | MP0002229_neurodegeneration | 0.85904640 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.85634113 |
| 116 | MP0003942_abnormal_urinary_system | 0.84714454 |
| 117 | MP0004742_abnormal_vestibular_system | 0.84422422 |
| 118 | MP0002163_abnormal_gland_morphology | 0.83254302 |
| 119 | MP0009046_muscle_twitch | 0.83199550 |
| 120 | MP0002882_abnormal_neuron_morphology | 0.81174791 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.80215074 |
| 122 | MP0003631_nervous_system_phenotype | 0.79012277 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.78599218 |
| 124 | MP0003329_amyloid_beta_deposits | 0.78364355 |
| 125 | MP0005195_abnormal_posterior_eye | 0.77986772 |
| 126 | MP0002092_abnormal_eye_morphology | 0.77263505 |
| 127 | MP0003861_abnormal_nervous_system | 0.76820224 |
| 128 | MP0001177_atelectasis | 0.76655340 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.75638489 |
| 130 | MP0008995_early_reproductive_senescence | 0.75308251 |
| 131 | MP0005508_abnormal_skeleton_morphology | 0.74757006 |
| 132 | MP0006276_abnormal_autonomic_nervous | 0.73624846 |
| 133 | MP0004142_abnormal_muscle_tone | 0.73610889 |
| 134 | MP0000163_abnormal_cartilage_morphology | 0.73565977 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.72991706 |
| 136 | MP0000432_abnormal_head_morphology | 0.72716785 |
| 137 | MP0002090_abnormal_vision | 0.72426549 |
| 138 | MP0009745_abnormal_behavioral_response | 0.72220401 |
| 139 | MP0001299_abnormal_eye_distance/ | 0.70939055 |
| 140 | MP0001672_abnormal_embryogenesis/_devel | 0.69467059 |
| 141 | MP0005380_embryogenesis_phenotype | 0.69467059 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.69161521 |
| 143 | MP0005367_renal/urinary_system_phenotyp | 0.68617690 |
| 144 | MP0000516_abnormal_urinary_system | 0.68617690 |
| 145 | MP0003880_abnormal_central_pattern | 0.67982356 |
| 146 | MP0002081_perinatal_lethality | 0.66439597 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.66108424 |
| 148 | MP0002084_abnormal_developmental_patter | 0.64566693 |
| 149 | MP0002234_abnormal_pharynx_morphology | 0.64104265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.33695477 |
| 2 | Hepatoblastoma (HP:0002884) | 5.98039452 |
| 3 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.82945271 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 4.62438624 |
| 5 | Myokymia (HP:0002411) | 4.58140783 |
| 6 | Focal motor seizures (HP:0011153) | 4.37233057 |
| 7 | Polyphagia (HP:0002591) | 4.28068162 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 4.15406483 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 3.92252623 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.92252623 |
| 11 | Gait imbalance (HP:0002141) | 3.83464335 |
| 12 | Rib fusion (HP:0000902) | 3.61358758 |
| 13 | Bifid tongue (HP:0010297) | 3.60076145 |
| 14 | Medial flaring of the eyebrow (HP:0010747) | 3.59243459 |
| 15 | Limb dystonia (HP:0002451) | 3.51261739 |
| 16 | Multiple enchondromatosis (HP:0005701) | 3.46247640 |
| 17 | Congenital primary aphakia (HP:0007707) | 3.40203181 |
| 18 | Abnormality of the fovea (HP:0000493) | 3.33450263 |
| 19 | Nephrogenic diabetes insipidus (HP:0009806) | 3.20877064 |
| 20 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.18429164 |
| 21 | Focal seizures (HP:0007359) | 3.12222879 |
| 22 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.09370846 |
| 23 | Amyotrophic lateral sclerosis (HP:0007354) | 3.02802235 |
| 24 | Neoplasm of the heart (HP:0100544) | 3.00360693 |
| 25 | Hyperventilation (HP:0002883) | 2.96750262 |
| 26 | True hermaphroditism (HP:0010459) | 2.95805388 |
| 27 | Nephronophthisis (HP:0000090) | 2.92915483 |
| 28 | Pancreatic fibrosis (HP:0100732) | 2.91596406 |
| 29 | Pancreatic cysts (HP:0001737) | 2.88812595 |
| 30 | Abnormality of the labia minora (HP:0012880) | 2.86446784 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.85661639 |
| 32 | Ependymoma (HP:0002888) | 2.83698935 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.83663046 |
| 34 | Vaginal atresia (HP:0000148) | 2.76623142 |
| 35 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.76605463 |
| 36 | Hemiparesis (HP:0001269) | 2.75044405 |
| 37 | Genital tract atresia (HP:0001827) | 2.74539459 |
| 38 | Abnormality of the salivary glands (HP:0010286) | 2.69432975 |
| 39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.69160251 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.65055004 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.65055004 |
| 42 | Poor suck (HP:0002033) | 2.64091886 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.58813600 |
| 44 | Embryonal renal neoplasm (HP:0011794) | 2.58785261 |
| 45 | Specific learning disability (HP:0001328) | 2.57422131 |
| 46 | Testicular atrophy (HP:0000029) | 2.56549595 |
| 47 | Retinal dysplasia (HP:0007973) | 2.55374939 |
| 48 | Neoplasm of striated muscle (HP:0009728) | 2.54648616 |
| 49 | Amblyopia (HP:0000646) | 2.51546956 |
| 50 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51474450 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.48615987 |
| 52 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.48243057 |
| 53 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.48243057 |
| 54 | Type II lissencephaly (HP:0007260) | 2.47393295 |
| 55 | Generalized hypotonia (HP:0001290) | 2.47246166 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.43700574 |
| 57 | Symptomatic seizures (HP:0011145) | 2.43340558 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.42558237 |
| 59 | Epileptic encephalopathy (HP:0200134) | 2.41465900 |
| 60 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.41209031 |
| 61 | Progressive cerebellar ataxia (HP:0002073) | 2.40829072 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.40328011 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39068812 |
| 64 | Lissencephaly (HP:0001339) | 2.37833409 |
| 65 | Acute encephalopathy (HP:0006846) | 2.37489895 |
| 66 | Horizontal nystagmus (HP:0000666) | 2.37449731 |
| 67 | Split foot (HP:0001839) | 2.33728898 |
| 68 | Generalized tonic-clonic seizures (HP:0002069) | 2.33453554 |
| 69 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.32666908 |
| 70 | Fused cervical vertebrae (HP:0002949) | 2.31741545 |
| 71 | Inability to walk (HP:0002540) | 2.31034476 |
| 72 | Partial duplication of thumb phalanx (HP:0009944) | 2.30674405 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.30451619 |
| 74 | Septo-optic dysplasia (HP:0100842) | 2.28001225 |
| 75 | Resting tremor (HP:0002322) | 2.26067367 |
| 76 | Anomalous pulmonary venous return (HP:0010772) | 2.26028255 |
| 77 | Renal duplication (HP:0000075) | 2.25734200 |
| 78 | Abnormality of the renal medulla (HP:0100957) | 2.25423570 |
| 79 | Spastic tetraplegia (HP:0002510) | 2.24414466 |
| 80 | Methylmalonic aciduria (HP:0012120) | 2.24036040 |
| 81 | Osteomalacia (HP:0002749) | 2.23167517 |
| 82 | Shawl scrotum (HP:0000049) | 2.22629491 |
| 83 | Optic nerve hypoplasia (HP:0000609) | 2.21598918 |
| 84 | Absence seizures (HP:0002121) | 2.20224328 |
| 85 | Abnormality of the astrocytes (HP:0100707) | 2.18463181 |
| 86 | Astrocytoma (HP:0009592) | 2.18463181 |
| 87 | Action tremor (HP:0002345) | 2.17893405 |
| 88 | Excessive salivation (HP:0003781) | 2.17297876 |
| 89 | Short tibia (HP:0005736) | 2.17061754 |
| 90 | Tetraplegia (HP:0002445) | 2.16835861 |
| 91 | Postaxial hand polydactyly (HP:0001162) | 2.11876497 |
| 92 | Poor coordination (HP:0002370) | 2.11268561 |
| 93 | Failure to thrive in infancy (HP:0001531) | 2.10837518 |
| 94 | Rhabdomyosarcoma (HP:0002859) | 2.07429506 |
| 95 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.06785834 |
| 96 | Villous atrophy (HP:0011473) | 2.06785834 |
| 97 | Esotropia (HP:0000565) | 2.05988918 |
| 98 | Methylmalonic acidemia (HP:0002912) | 2.05730365 |
| 99 | Increased CSF lactate (HP:0002490) | 2.03875508 |
| 100 | Ketoacidosis (HP:0001993) | 2.03239428 |
| 101 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03029694 |
| 102 | Hepatocellular necrosis (HP:0001404) | 2.01723080 |
| 103 | Progressive inability to walk (HP:0002505) | 2.01328595 |
| 104 | Progressive muscle weakness (HP:0003323) | 2.01312155 |
| 105 | Upper limb muscle weakness (HP:0003484) | 2.00704309 |
| 106 | Partial duplication of the phalanx of hand (HP:0009999) | 1.99469661 |
| 107 | Abnormality of the pubic bones (HP:0003172) | 1.99441193 |
| 108 | Pachygyria (HP:0001302) | 1.99351836 |
| 109 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.99174709 |
| 110 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96959389 |
| 111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96959389 |
| 112 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96959389 |
| 113 | Ectopic anus (HP:0004397) | 1.96473164 |
| 114 | Sensory axonal neuropathy (HP:0003390) | 1.96454150 |
| 115 | Abnormality of chromosome segregation (HP:0002916) | 1.95373075 |
| 116 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95042675 |
| 117 | Abnormality of the musculature of the hand (HP:0001421) | 1.94367562 |
| 118 | Absent speech (HP:0001344) | 1.93990323 |
| 119 | Rectovaginal fistula (HP:0000143) | 1.93790557 |
| 120 | Rectal fistula (HP:0100590) | 1.93790557 |
| 121 | Occipital encephalocele (HP:0002085) | 1.93695258 |
| 122 | Hand muscle atrophy (HP:0009130) | 1.92718268 |
| 123 | Preauricular pit (HP:0004467) | 1.92710841 |
| 124 | Periauricular skin pits (HP:0100277) | 1.92710841 |
| 125 | Hepatic necrosis (HP:0002605) | 1.91608676 |
| 126 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.91244734 |
| 127 | Atonic seizures (HP:0010819) | 1.90997430 |
| 128 | Scrotal hypoplasia (HP:0000046) | 1.90859096 |
| 129 | Nasolacrimal duct obstruction (HP:0000579) | 1.89718156 |
| 130 | Abnormality of the pulmonary veins (HP:0011718) | 1.89370408 |
| 131 | Cortical visual impairment (HP:0100704) | 1.88552687 |
| 132 | Intestinal atresia (HP:0011100) | 1.88387192 |
| 133 | Large for gestational age (HP:0001520) | 1.88150696 |
| 134 | Missing ribs (HP:0000921) | 1.88102451 |
| 135 | Sclerocornea (HP:0000647) | 1.87920603 |
| 136 | Febrile seizures (HP:0002373) | 1.87056044 |
| 137 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.86665434 |
| 138 | Skin nodule (HP:0200036) | 1.86599405 |
| 139 | Cystic liver disease (HP:0006706) | 1.86038687 |
| 140 | Short humerus (HP:0005792) | 1.85963169 |
| 141 | Anencephaly (HP:0002323) | 1.85477286 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 1.85357591 |
| 143 | Narrow forehead (HP:0000341) | 1.84415930 |
| 144 | Status epilepticus (HP:0002133) | 1.83955019 |
| 145 | Abnormality of the corticospinal tract (HP:0002492) | 1.83545618 |
| 146 | Dysautonomia (HP:0002459) | 1.83505525 |
| 147 | Broad foot (HP:0001769) | 1.82654417 |
| 148 | Decreased testicular size (HP:0008734) | 1.81747221 |
| 149 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81376199 |
| 150 | Humeroradial synostosis (HP:0003041) | 1.81187370 |
| 151 | Synostosis involving the elbow (HP:0003938) | 1.81187370 |
| 152 | Cortical dysplasia (HP:0002539) | 1.81047883 |
| 153 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.80563319 |
| 154 | Growth hormone deficiency (HP:0000824) | 1.80434931 |
| 155 | Muscular hypotonia of the trunk (HP:0008936) | 1.80239748 |
| 156 | Abnormal hair whorl (HP:0010721) | 1.80057671 |
| 157 | Sleep apnea (HP:0010535) | 1.79759137 |
| 158 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.79568927 |
| 159 | Agitation (HP:0000713) | 1.79548856 |
| 160 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.78312360 |
| 161 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78176865 |
| 162 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.77819217 |
| 163 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.77753457 |
| 164 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77407514 |
| 165 | Hypoplasia of the brainstem (HP:0002365) | 1.77407514 |
| 166 | Oligodactyly (hands) (HP:0001180) | 1.76960706 |
| 167 | Abnormal lung lobation (HP:0002101) | 1.76438688 |
| 168 | Broad-based gait (HP:0002136) | 1.76070416 |
| 169 | Hyperglycinemia (HP:0002154) | 1.76005250 |
| 170 | Generalized myoclonic seizures (HP:0002123) | 1.75410989 |
| 171 | Optic disc pallor (HP:0000543) | 1.75275524 |
| 172 | Mutism (HP:0002300) | 1.75098609 |
| 173 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.74415966 |
| 174 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.74324464 |
| 175 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.74324464 |
| 176 | Open mouth (HP:0000194) | 1.74141274 |
| 177 | Gout (HP:0001997) | 1.74043599 |
| 178 | Preauricular skin tag (HP:0000384) | 1.73597820 |
| 179 | Vaginal fistula (HP:0004320) | 1.73284417 |
| 180 | Dialeptic seizures (HP:0011146) | 1.73219655 |
| 181 | Skin pits (HP:0100276) | 1.71072840 |
| 182 | Visual hallucinations (HP:0002367) | 1.69579130 |
| 183 | Macroorchidism (HP:0000053) | 1.69333644 |
| 184 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.68226391 |
| 185 | Broad alveolar ridges (HP:0000187) | 1.67623468 |
| 186 | Abnormality of the lacrimal duct (HP:0011481) | 1.67346660 |
| 187 | Drooling (HP:0002307) | 1.67073521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.89278812 |
| 2 | GRK5 | 5.13880614 |
| 3 | ERN1 | 3.91524744 |
| 4 | MAP4K2 | 3.25510381 |
| 5 | NTRK1 | 3.01137658 |
| 6 | GRK6 | 2.83622671 |
| 7 | TYRO3 | 2.75157040 |
| 8 | ADRBK2 | 2.68812360 |
| 9 | INSRR | 2.54733661 |
| 10 | GRK1 | 2.36914358 |
| 11 | BCKDK | 2.32660543 |
| 12 | WNK1 | 2.27577627 |
| 13 | MAPK15 | 2.25317452 |
| 14 | HIPK2 | 2.18258085 |
| 15 | GRK7 | 2.15479285 |
| 16 | MAPK7 | 2.05503013 |
| 17 | NTRK3 | 2.05158091 |
| 18 | PRKD3 | 2.03179959 |
| 19 | AKT3 | 1.94829346 |
| 20 | PINK1 | 1.91550192 |
| 21 | TRIM28 | 1.84786847 |
| 22 | CSNK1G2 | 1.83747035 |
| 23 | WNK3 | 1.83580279 |
| 24 | PNCK | 1.80017415 |
| 25 | CSNK1G3 | 1.71505406 |
| 26 | MARK1 | 1.71031965 |
| 27 | MATK | 1.64325716 |
| 28 | PLK2 | 1.62841851 |
| 29 | MOS | 1.62487734 |
| 30 | CSF1R | 1.60779617 |
| 31 | MAP2K4 | 1.50830456 |
| 32 | CSNK1G1 | 1.48635821 |
| 33 | PASK | 1.48592251 |
| 34 | MARK2 | 1.48278683 |
| 35 | TGFBR2 | 1.47055481 |
| 36 | EPHA3 | 1.42026054 |
| 37 | CSNK1A1L | 1.41826651 |
| 38 | UHMK1 | 1.37817110 |
| 39 | TNIK | 1.35112389 |
| 40 | PDGFRA | 1.32004399 |
| 41 | ADRBK1 | 1.26838519 |
| 42 | CDK19 | 1.24026619 |
| 43 | NTRK2 | 1.23631714 |
| 44 | DAPK2 | 1.22432816 |
| 45 | TTK | 1.21214447 |
| 46 | PAK3 | 1.15038043 |
| 47 | CAMK4 | 1.12353135 |
| 48 | MAP3K9 | 1.09563948 |
| 49 | EPHB2 | 1.07788702 |
| 50 | PRKG2 | 1.06830234 |
| 51 | DYRK3 | 1.01402756 |
| 52 | WNK4 | 0.98860114 |
| 53 | FRK | 0.97910711 |
| 54 | ERBB3 | 0.97753857 |
| 55 | FGFR2 | 0.96294208 |
| 56 | CAMK2A | 0.95638482 |
| 57 | TSSK6 | 0.94552220 |
| 58 | FGFR3 | 0.93339958 |
| 59 | BMPR1B | 0.90728170 |
| 60 | MAP3K2 | 0.90105121 |
| 61 | PTK2 | 0.87538459 |
| 62 | EPHA4 | 0.87051705 |
| 63 | PKN1 | 0.85984592 |
| 64 | CASK | 0.85026804 |
| 65 | DYRK2 | 0.84996108 |
| 66 | DYRK1A | 0.83198122 |
| 67 | MAPKAPK5 | 0.78981589 |
| 68 | CAMK2B | 0.78718388 |
| 69 | SGK494 | 0.78673619 |
| 70 | SGK223 | 0.78673619 |
| 71 | TIE1 | 0.78157942 |
| 72 | CCNB1 | 0.77026526 |
| 73 | PAK6 | 0.72608604 |
| 74 | CAMK1 | 0.72575412 |
| 75 | RPS6KA4 | 0.68813911 |
| 76 | PRKCG | 0.68633556 |
| 77 | PIM2 | 0.65873019 |
| 78 | CHEK2 | 0.65550458 |
| 79 | CAMK2G | 0.64943679 |
| 80 | PRKCI | 0.64685052 |
| 81 | PRKD2 | 0.64071423 |
| 82 | CDC42BPA | 0.63864317 |
| 83 | MAP3K4 | 0.63023897 |
| 84 | MAPK13 | 0.62713268 |
| 85 | EPHA2 | 0.62386085 |
| 86 | ARAF | 0.61983125 |
| 87 | VRK1 | 0.61619212 |
| 88 | ALK | 0.60869795 |
| 89 | PRKCZ | 0.60131865 |
| 90 | CAMKK2 | 0.60006401 |
| 91 | PRKCH | 0.59251928 |
| 92 | RPS6KA5 | 0.58890402 |
| 93 | OXSR1 | 0.57089769 |
| 94 | CAMK2D | 0.56851519 |
| 95 | CDK5 | 0.53767502 |
| 96 | IGF1R | 0.53309599 |
| 97 | CDK3 | 0.52494093 |
| 98 | CDK7 | 0.51964279 |
| 99 | TESK1 | 0.51384372 |
| 100 | MAPK12 | 0.50671497 |
| 101 | LATS2 | 0.50527758 |
| 102 | PAK4 | 0.48384088 |
| 103 | ZAK | 0.48092657 |
| 104 | PHKG2 | 0.47407315 |
| 105 | PHKG1 | 0.47407315 |
| 106 | KSR2 | 0.46337009 |
| 107 | MAPK10 | 0.45701344 |
| 108 | NUAK1 | 0.45122231 |
| 109 | PRKG1 | 0.45082170 |
| 110 | PRPF4B | 0.43959342 |
| 111 | MINK1 | 0.43401788 |
| 112 | ERBB2 | 0.43334682 |
| 113 | DYRK1B | 0.42672326 |
| 114 | CDK14 | 0.42512326 |
| 115 | CDK15 | 0.42162823 |
| 116 | MAP2K6 | 0.42028325 |
| 117 | STK10 | 0.40398336 |
| 118 | CDK18 | 0.40313850 |
| 119 | PRKACA | 0.39957757 |
| 120 | AKT2 | 0.39097036 |
| 121 | STK16 | 0.37819220 |
| 122 | FER | 0.37406458 |
| 123 | STK39 | 0.37136378 |
| 124 | TXK | 0.36947698 |
| 125 | MAP3K12 | 0.35580383 |
| 126 | CDK11A | 0.35149258 |
| 127 | CSK | 0.35012755 |
| 128 | TAOK1 | 0.34688860 |
| 129 | CSNK1E | 0.34434988 |
| 130 | PRKCA | 0.34386737 |
| 131 | MTOR | 0.33950234 |
| 132 | PRKACG | 0.33828477 |
| 133 | GSK3A | 0.33754467 |
| 134 | DDR2 | 0.33226170 |
| 135 | SGK2 | 0.33066133 |
| 136 | NME1 | 0.32996393 |
| 137 | MAP3K7 | 0.32039191 |
| 138 | CAMKK1 | 0.31984068 |
| 139 | BCR | 0.31983941 |
| 140 | RPS6KA3 | 0.31979966 |
| 141 | GSK3B | 0.30927100 |
| 142 | ERBB4 | 0.29621828 |
| 143 | PRKAA1 | 0.28375598 |
| 144 | MAP2K7 | 0.26522175 |
| 145 | PRKCE | 0.26466287 |
| 146 | MAPK14 | 0.26206578 |
| 147 | CHEK1 | 0.25927268 |
| 148 | INSR | 0.25661689 |
| 149 | KSR1 | 0.24311179 |
| 150 | LIMK1 | 0.24187760 |
| 151 | SIK2 | 0.23614572 |
| 152 | MAP3K1 | 0.23433739 |
| 153 | PLK1 | 0.23127143 |
| 154 | CSNK1A1 | 0.22616665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.96264080 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.75022228 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.32316342 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.91524775 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.87495308 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.76066601 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.56647784 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.47659448 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.17074069 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14896321 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.13905313 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12312471 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.10568574 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.09897976 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07795235 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.93964106 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91646732 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.88208200 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.86830597 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.84272941 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73676292 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.71272108 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69600150 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68598464 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.66600934 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65230016 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50942468 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.45385252 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43914266 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39163227 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37940032 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.36314374 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36271369 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.33979903 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32297735 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31445467 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28885924 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.26214420 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26039187 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24959847 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24730611 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.23932795 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22135729 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20922730 |
| 45 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.20566689 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19319283 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.18597247 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17631435 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16153547 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.11947008 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04452488 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.04418844 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01410721 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00296555 |
| 55 | Morphine addiction_Homo sapiens_hsa05032 | 1.00180232 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99725063 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98699043 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96551888 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96036639 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94659329 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93911652 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93642200 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93638498 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.93200747 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92616263 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92333290 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89780647 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.89086780 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86185149 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84843420 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.84166363 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.84075158 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83722979 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83721250 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83413642 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82721131 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81462889 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81337289 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.79381683 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78573144 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78285547 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78075670 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77539344 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75923335 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75802281 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74061158 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74023300 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.72827766 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72146251 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70822661 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.67356997 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66947314 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66424726 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64917882 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64695689 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63262852 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62895197 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.62557273 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61944096 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61879134 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61809256 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61264816 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60787321 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59981818 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59304901 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58187663 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57050964 |
| 108 | Proteasome_Homo sapiens_hsa03050 | 0.56116479 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53328653 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53262164 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52924295 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52785863 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.52162339 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51526067 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51377262 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51303728 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50305548 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47949356 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47929121 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47542197 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47420856 |
| 122 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46893715 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.46172583 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45694073 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45651791 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45536186 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.45132299 |
| 128 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45073442 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44455630 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.44186095 |
| 131 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44096480 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42834410 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41766309 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41382422 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41312686 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.40550145 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39959369 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39568057 |
| 139 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38583692 |
| 140 | RNA degradation_Homo sapiens_hsa03018 | 0.36098275 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32648616 |
| 142 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31684277 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30330360 |
| 144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28370517 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27964925 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27186581 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26519543 |
| 148 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25264021 |
| 149 | Purine metabolism_Homo sapiens_hsa00230 | 0.24374306 |

